Back to Self-Funded Mastery

Published: 2026-11-04 | By Paul H. Flowers Jr.

A Stop-Loss Policy Is Not a Pharmacy Strategy

Stop-loss coverage has an important job in a self-funded health plan: it can limit the employer’s exposure when a covered claim reaches the policy’s attachment point and the policy terms are met. That protection belongs in a sound funding plan.

It does not decide which pharmacy claims occur, whether a member can afford a prescription, whether the plan is paying the agreed price, or whether the clinical rules are working. A stop-loss policy is risk protection. It is not a pharmacy strategy.

The source idea: pharmacy pressure is reshaping employer budgets

Business Group on Health recently described a volatile employer cost environment in which pharmacy costs and expensive therapies add to medical trend pressure. Its point is broader than any one drug class: plan sponsors are being pushed to examine the design, partners, and decisions behind rising cost rather than treating a forecast as the whole problem.

For a self-funded employer, that creates a practical governance question. What happens before a claim is large enough to reach stop-loss? The answer is where pharmacy strategy lives: benefit design, formulary governance, clinical criteria, member support, contracting, reporting, and a clear process for reviewing exceptions.

Know what the policy does and does not absorb

A high-cost specialty drug, cell or gene therapy, or GLP-1 regimen may create material exposure for a plan. Whether and when stop-loss responds depends on the specific policy, including its attachment point, exclusions, limitations, reimbursement process, and the treatment of eligible expenses. No employer should assume that a large invoice automatically becomes a stop-loss recovery.

That is why the benefit committee should review stop-loss and pharmacy together without confusing their roles. The committee should understand the risk transfer, then separately ask whether the plan has the information and authority to manage the drug benefit responsibly before claims accumulate.

Build an operating view of pharmacy

A usable pharmacy strategy is not a one-time formulary approval. It is a repeatable review of what the plan is buying and what members experience. Start with plain questions: Which therapies and conditions are driving spend? What is changing in utilization, unit cost, and member out-of-pocket expense? Which clinical programs apply, and who can explain their criteria? What amounts are paid to the PBM, pharmacies, manufacturers, or other parties under the contract?

Then make the reports decision-ready. A CFO should be able to see the major categories of spend and the assumptions behind them. An HR leader should be able to explain the member pathway. The people assigned to fiduciary or operating oversight should have the contract terms, audit rights, and a calendar for review. Data without an owner is only a more expensive spreadsheet.

Do not solve volatility by moving it blindly

Employers sometimes react to a troubling forecast by shifting more cost to employees, adding a program, or relying on a promise of future savings. Each may have a place, but none substitutes for a documented decision process. A change should be tested against clinical appropriateness, member access, total plan cost, administrative workload, and the contract language that governs payment and performance.

That is especially important for Midwest employers with a mix of hourly and salaried workers, multiple locations, or limited local specialist access. A restriction that looks tidy in a renewal presentation can create delayed care, abandoned prescriptions, or a call-center burden if the member path has not been designed and communicated.

Keep the financing conversation honest

Paul H. Flowers Jr. at Superior Insurance Advisors and Paul.Health helps employers connect plan financing to the operating decisions that produce claims. The aim is not to promise a particular outcome or to treat every high-cost medicine as inappropriate. It is to give leadership a clear decision file: what the plan covers, who is accountable, what the contract says, what members encounter, and what evidence will be reviewed at the next meeting.

Source: Business Group on Health, “Taking Action on Health Care Costs: A Business Group on Health Viewpoint”, March 3, 2026, accessed November 4, 2026. The source is market context, not a recommendation, forecast, or guarantee for a particular employer. This is original educational commentary, not legal, tax, investment, or fiduciary advice. Plan documents, contracts, stop-loss policies, and applicable law govern.

Five questions for the next pharmacy and stop-loss review

Before you rely on stop-loss to calm a pharmacy forecast, can you explain the operating decisions that happen before a claim ever reaches the policy?